Legal News

Supreme Court Declines to Hear Appeal to Reclassify Marijuana
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

On Monday, the U.S. Supreme Court refused to hear an appeal led by the Americans for Safe Access that sought the reclassification of marijuana and remove it from DEA’s Schedule I list of drugs under the Controlled Substance Act.

Marijuana advocacy groups had sought a review of a DC Circuit Court of Appeals decision that upheld DEA’s ruling that such change in classification of marijuana can be done only if the FDA recognized marijuana for acceptable medical use.

  
What
Where


In spite of the growing body of research supporting the medicinal effects and benefits of marijuana, the federal government continues to classify marijuana under Schedule I along with drugs like Heroin, MDMA and LSD. The DEA keeps to its position that marijuana continues to be a dangerous drug even though there is widespread use of medical marijuana across the world and 20 states of the USA.

In the order that was appealed against, the DC Circuit had observed that a 1999 report from the Institute of Medicine, “does indeed suggest that marijuana might have medical benefits.” However, the court also concluded that DEA had interpreted the report reasonably and further studies were needed before reclassification of marijuana. In the words of the DC Circuit, “such studies do not exist.”

The Supreme Court is generally reluctant to interfere with administrative and lower court orders unless things are sufficiently high-profile, and the refusal to hear the appeal was no surprise.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




Even though Americans for Safe Access requested the Drug Enforcement Administration to reclassify marijuana in 2002, the agency took nine years to reject that request. In 2011, the DEA said that marijuana’s medical efficacy was yet unproved given that there were no large-scale studies involving large numbers of patients. Given that it is DEA’s own stand on marijuana that prevents such large-scale studies from taking place, the rationale for not declassifying marijuana seems little more than stubborn opposition rather than unbiased assessment.

Marijuana image source: Wikimedia commons





 

RELEVANT JOBS

DEPUTY STAFF COUNSEL / ATTORNEY

USA-CA-Auburn

JOIN OUR OUTSTANDING TEAM OF PROFESSIONALS! DEPUTY STAFF COUNSEL / ATTORNEY $129,615 - $165,42...

Apply now

Associate Attorney

USA-CA-Rohnert Park

Zimmerman Pavone LLP is looking for an attorney admitted to practice in California who is inter...

Apply now

Labor & Employment Partner in Houston, Austin or Dallas (Work From Home)

USA-TX-Houston

Culhane Meadows PLLC, one of the largest non-traditional distributed law firms in the country, ...

Apply now

Labor & Employment Group partner in Dallas, Austin or Houston (Work From Home)

USA-TX-Dallas

Culhane Meadows PLLC, one of the largest non-traditional distributed law firms in the country, is...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Personal Injury Litigator

USA-VA-Fairfax

Northern Virginia office of our client is seeking a personal injury litigator with 4+ years of stron...

Apply Now

Associate Attorney

USA-CA-Larkspur

Larkspur office of our client seeks an associate attorney with 4-6 years of experience/background pr...

Apply Now

Associate Attorney

USA-MI-Bloomfield Hills

Bloomfield Hills office of a BCG Attorney Search Top Ranked Law Firm seeks an associate attorney wit...

Apply Now

SEARCH IN ARCHIVE

To Top